[Chemotherapy for biliary tract infection (XXXIII). Tissue concentration of NY-198 in gallbladder, biliary excretion and clinical effects].
Tanimura
H
H
Aoki
Y
Y
Uesaka
K
K
Kasano
Y
Y
Nakai
T
T
Kitamura
T
T
Mukaihara
S
S
Tamura
K
K
Yotsumoto
F
F
Terao
R
R
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000890:Anti-Infective Agents / Q000493:pharmacokinetics* / Q000627:therapeutic use; D001424:Bacterial Infections / Q000188:drug therapy*; D001646:Bile / Q000378:metabolism*; D002761:Cholangitis / Q000188:drug therapy*; D002764:Cholecystitis / Q000188:drug therapy*; D004341:Drug Evaluation; D015365:Enoxacin / Q000493:pharmacokinetics; D005260:Female; D024841:Fluoroquinolones; D005704:Gallbladder / Q000378:metabolism*; D006801:Humans; D008297:Male; D008875:Middle Aged; D015363:Quinolones; D014018:Tissue Distribution
D000890:Anti-Infective Agents; D024841:Fluoroquinolones; D015363:Quinolones; D015365:Enoxacin; C053091:lomefloxacin